Janus kinase 2
Comprehensive kinase profile of pacritinib, a nonmyelosuppressive Janus kinase 2 inhibitor
9
Integrated in Silico Docking and MoMA Simulation Methods Reveal Rottlerin as a Potent Janus kinase 2 (JAK2) Inhibitor
10
Splenomegaly in myelofibrosis—new options for therapy and the therapeutic potential of Janus kinase 2 inhibitors
7
Partial suppression of M1 microglia by Janus kinase 2 inhibitor does not protect against neurodegeneration in animal models of amyotrophic lateral sclerosis
8
Leptin induces upregulation of sphingosine kinase 1 in oestrogen receptor negative breast cancer via Src family kinase mediated, janus kinase 2 independent pathway
15
Combination of the ABL kinase inhibitor imatinib with the Janus kinase 2 inhibitor TG101348 for targeting residual BCR-ABL-positive cells
11
A highly selective, orally active inhibitor of Janus kinase 2, CEP 33779, ablates disease in two mouse models of rheumatoid arthritis
15
Download Download PDF
12
Biologically inactive growth hormone caused by an amino acid substitution
8
A case of minor BCR-ABL1 positive acute lymphoblastic leukemia following essential thrombocythemia and originating from a clone distinct from that harboring the JAK2-V617F mutation
5
Tyrosine 625 plays a key role and cooperates with tyrosine 630 in MPL W515L-induced signaling and myeloproliferative neoplasms
13
Cartilage preservation by inhibition of Janus kinase 3 in two rodent models of rheumatoid arthritis
9
Interleukin 27 polymorphisms in HCV RNA positive patients: is there an impact on response to interferon therapy?
6
TRAF1 Is a Critical Regulator of JNK Signaling by the TRAF-Binding Domain of the Epstein-Barr Virus-Encoded Latent Infection Membrane Protein 1 but Not CD40
13
<p>Unleashing The Potential Of Multiple-Targeted Therapies In Hepatobiliary Cancers: Two Cases, Cocktail Therapy With Nine Molecular Targeted Agents And Long-Lasting Survival</p>
5
<p>Targeting IFN/STAT1 Pathway as a Promising Strategy to Overcome Radioresistance</p>
14
Incorporating Radiation Oncology into Immunotherapy: proceedings from the ASTRO-SITC-NCI immunotherapy workshop
8
A Robust Fabrication Method for Amphiphilic Janus Particles via Immobilization on Polycarbonate Microspheres Karthik Ananth Mani 1, Noga Yaakov1 , Yafit Itzhaik Alkotzer 1, Evgeni Zelikman2 , and Guy Mechrez 1,
27
A role for type 111 interferons in the natural killer cell immune response to virus
226
A screen for peptide agonists of the G CSF receptor
6